Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2003-03-20
2010-11-16
Bristol, Lynn (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S412000, C530S810000, C530S825000
Reexamination Certificate
active
07834158
ABSTRACT:
The present invention relates to an immunoglobulin-binding protein, wherein at least one asparagine residue has been mutated to an amino acid other than glutamine or aspartic acid, which mutation confers an increased chemical stability at pH-values of up to about 13-14 compared to the parental molecule. The protein can for example be derived from a protein capable of binding to other regions of the immunoglobulin molecule than the complementarity determining regions (CDR), such as protein A, and preferably the B-domain of Staphylococcal protein A. The invention also relates to a matrix for affinity separation, which comprises an immunoglobulin-binding protein as ligand coupled to a solid support, in which protein ligand at least one asparagine residue has been mutated to an amino acid other than glutamine.
REFERENCES:
patent: WO 00/23580 (2000-04-01), None
Burgess et al, Journal of Cell Biology vol. 111 Nov. 1990 2129-2138.
Lazar et al Molecular and Cellular Biology Mar. 1988 vol. 8 No. 3 1247-1252.
Schwartz et al, Proc Natl Acad Sci USA vol. 84:6408-6411 (1987).
Lin et al Biochemistry USA vol. 14:1559-1563 (1975).
Ibragimova and Eade (Biophysical Journal, Oct. 1999, vol. 77, pp. 2191-2198).
T. Geiger, et al., “Deamidation, Isomerization, and Racemization at Asparaginyl and Aspartyl Residues in Peptides”,The Journal of Biological Chemistry, vol. 262, Jan. 15, 1987 p. 785-794.
S. Gülich, et al., “Stability towards alkaline conditions can be engineered into a protein ligand”,Journal of Biotechnology, vol. 80, 2000, p. 169-178.
B. Nilsson, et al., “A synthetic IgG-binding domain based on staphylococcal protein A”,Protein Engineering, vol. 1, 1987, p. 107-113.
L. Jendeberg, et al., “Kinetic analysis of the interaction between protein A domain variants and human Fc using plasmon resonance detection”,Journal of Molecular Recognition, vol. 8, 1995, p. 270-278.
L. Cedergren, et al., “Mutational analysis of the interaction between staphylococcal protein A and human IgG-1”,Protein Engineering, vol. 6, 1993, p. 441-448.
A. Karlstrom, et al., “Dual labeling of the binding protein allows for specific fluorescence detection of native protein”,Analytical Biochemistry, vol. 295, Aug. 1, 2001, p. 22-30.
Linhult, M., et al., “Improving the Tolerance of a Protein A Analogue to Repeated Alkaline Exposures Using Bypass Mutagenesis Approach” Proteins: Structure, Function, and Bioinformatics 55:407-416 (2004).
Bristol Lynn
GE Healthcare Bio-Sciences AB
Ji Yonggang
LandOfFree
Mutated immunoglobulin-binding protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mutated immunoglobulin-binding protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutated immunoglobulin-binding protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4200699